Skip to main content
Top
Published in: Indian Journal of Gastroenterology 3/2023

24-05-2023 | Computed Tomography | Original Article

Simple bedside tests of muscle strength and function correlate with computed tomography-skeletal muscle index for assessment of sarcopenia in cirrhosis

Authors: Surender Singh, Sunil Taneja, Akash Roy, Sahaj Rathi, Arka De, Nipun Verma, Madhumita Premkumar, Ajay Duseja, R. K. Dhiman, Virendra Singh

Published in: Indian Journal of Gastroenterology | Issue 3/2023

Login to get access

Abstract

Background

Sarcopenia assessment can be done by skeletal muscle index (SMI) or bedside tests such as handgrip strength (HGS) and gait speed (GS).

Goals

This study evaluated the correlations of HGS and GS with SMI, health-related quality of life (HRQOL) and cognition and assessed them as predictors of mortality.

Study

As many as 116 outpatients with cirrhosis were included in this prospective cohort study. Assessment for sarcopenia was done by SMI, HGS and GS. HRQOL was assessed using the chronic liver disease questionnaire (CLDQ) and fatigue severity scale (FSS). Cognition was assessed by mini-mental state examination (MMSE). Correlations of HGS and GS with SMI, HRQOL and cognition were analyzed. Area under the curve (AUCs) were calculated to compare them as predictors of mortality.

Results

Alcoholic liver disease (47.4%) was the commonest etiology of cirrhosis followed by hepatitis C (12.9%). Sarcopenia was diagnosed in 64 (55.2%) patients. A strong correlation was seen between SMI and HGS (ρ = 0.78) and GS (ρ = 0.65). AUCs of GS (0.91 (95% confidence interval [CI], 0.85–0.96) was maximum, followed by HGS (95% CI, 0.86 [0.78–0.93] and SMI [95% CI, 0.8 0.71–0.88]) in predicting mortality (p > 0.05). CLDQ (3.2 vs. 5.6, p < 0.01) and MMSE scores (24.3 vs. 26.3, p < 0.01) were lower, whereas FSS score (5.7 vs. 3.1, p < 0.01) was higher in patients with sarcopenia. CLDQ (ρ = 0.83) and MMSE (ρ = 0.73) showed the strongest correlation with HGS, whereas FSS correlated well (ρ = 0.77) with GS.

Conclusions

Bedside tests of muscle strength and function, including HGS and GS, correlate strongly with SMI for sarcopenia assessment and prediction of mortality in patients with cirrhosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Montano-Loza AJ, Duarte-Rojo A, Meza-Junco J, et al. Inclusion of sarcopenia within MELD (MELD-sarcopenia) and the prediction of mortality in patients with cirrhosis: Clin Transl Gastroenterol. 2015;6:e102. Montano-Loza AJ, Duarte-Rojo A, Meza-Junco J, et al. Inclusion of sarcopenia within MELD (MELD-sarcopenia) and the prediction of mortality in patients with cirrhosis: Clin Transl Gastroenterol. 2015;6:e102.
2.
go back to reference Bhanji RA, Moctezuma-Velazquez C, Duarte-Rojo A, et al. Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis. Hepatol Int. 2018;12:377–86.CrossRefPubMed Bhanji RA, Moctezuma-Velazquez C, Duarte-Rojo A,  et al. Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis. Hepatol Int. 2018;12:377–86.CrossRefPubMed
3.
go back to reference Jeong JY, Lim S, Sohn JH, Lee JG, Jun DW, Kim Y. Presence of sarcopenia and its rate of change are independently associated with long-term mortality in patients with liver cirrhosis. J Korean Med Sci. 2018;33:e299.CrossRefPubMedPubMedCentral Jeong JY, Lim S, Sohn JH, Lee JG, Jun DW, Kim Y. Presence of sarcopenia and its rate of change are independently associated with long-term mortality in patients with liver cirrhosis. J Korean Med Sci. 2018;33:e299.CrossRefPubMedPubMedCentral
4.
go back to reference Sinclair M, Gow PJ, Grossmann M, Angus PW. Review article: Sarcopenia in cirrhosis - etiology, implications and potential therapeutic interventions. Aliment Pharmacol Ther. 2016;43:765–77.CrossRefPubMed Sinclair M, Gow PJ, Grossmann M, Angus PW. Review article: Sarcopenia in cirrhosis - etiology, implications and potential therapeutic interventions. Aliment Pharmacol Ther. 2016;43:765–77.CrossRefPubMed
5.
go back to reference Kim TY, Kim MY, Sohn JH, et al. Sarcopenia as a useful predictor for long-term mortality in cirrhotic patients with ascites. J Korean Med Sci. 2014;29:1253–9.CrossRefPubMedPubMedCentral Kim TY, Kim MY, Sohn JH, et al. Sarcopenia as a useful predictor for long-term mortality in cirrhotic patients with ascites. J Korean Med Sci. 2014;29:1253–9.CrossRefPubMedPubMedCentral
6.
go back to reference Ando Y, Ishigami M, Ito T, et al. Sarcopenia impairs health-related quality of life in cirrhotic patients. Eur J Gastroenterol Hepatol. 2019;31:1550–6.CrossRefPubMed Ando Y, Ishigami M, Ito T,  et al. Sarcopenia impairs health-related quality of life in cirrhotic patients. Eur J Gastroenterol Hepatol. 2019;31:1550–6.CrossRefPubMed
7.
go back to reference Hanai T, Shiraki M, Watanabe S, et al. Sarcopenia predicts minimal hepatic encephalopathy in patients with liver cirrhosis. Hepatol Res. 2017;47:1359–67.CrossRef Hanai T, Shiraki M, Watanabe S,  et al. Sarcopenia predicts minimal hepatic encephalopathy in patients with liver cirrhosis. Hepatol Res. 2017;47:1359–67.CrossRef
8.
go back to reference Kuo SZ, Ahmad M, Dunn MA, et al. Sarcopenia predicts post-transplant mortality in acutely Ill men undergoing urgent evaluation and liver transplantation. Transplantation. 2019;103:2312–7. Kuo SZ, Ahmad M, Dunn MA, et al. Sarcopenia predicts post-transplant mortality in acutely Ill men undergoing urgent evaluation and liver transplantation. Transplantation. 2019;103:2312–7.
9.
go back to reference Kumar V, Benjamin J, Shasthry V, et al. Sarcopenia in cirrhosis: Fallout on liver transplantation. J Clin Exp Hepatol. 2020;10:467–76.CrossRefPubMed Kumar V, Benjamin J, Shasthry V, et al. Sarcopenia in cirrhosis: Fallout on liver transplantation. J Clin Exp Hepatol. 2020;10:467–76.CrossRefPubMed
10.
go back to reference Tapper EB, Derstine B, Baki J, Su GL. Bedside measures of frailty and cognitive function correlate with sarcopenia in patients with cirrhosis. Dig Dis Sci. 2019;64:3652–9.CrossRefPubMed Tapper EB, Derstine B, Baki J, Su GL. Bedside measures of frailty and cognitive function correlate with sarcopenia in patients with cirrhosis. Dig Dis Sci. 2019;64:3652–9.CrossRefPubMed
11.
go back to reference Sidhu SS, Saggar K, Goyal O,et al. Muscle strength and physical performance, rather than muscle mass, correlate with mortality in end-stage liver disease. Eur J Gastroenterol Hepatol. 2021;33:555–64.CrossRefPubMed Sidhu SS, Saggar K, Goyal O,et al. Muscle strength and physical performance, rather than muscle mass, correlate with mortality in end-stage liver disease. Eur J Gastroenterol Hepatol. 2021;33:555–64.CrossRefPubMed
12.
go back to reference Gomez-Perez SL, Haus JM, Sheean P, et al. Measuring abdominal circumference and skeletal muscle from a single cross-sectional computed tomography image: A step-by-step guide for clinicians using National Institutes of Health ImageJ. J Parenter Enter Nutr. 2016;40:308–18.CrossRef Gomez-Perez SL, Haus JM, Sheean P, et al. Measuring abdominal circumference and skeletal muscle from a single cross-sectional computed tomography image: A step-by-step guide for clinicians using National Institutes of Health ImageJ. J Parenter Enter Nutr. 2016;40:308–18.CrossRef
13.
go back to reference Mourtzakis M, Prado CMM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab Physiol Appl Nutr Metab. 2008;33:997–1006.CrossRef Mourtzakis M, Prado CMM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab Physiol Appl Nutr Metab. 2008;33:997–1006.CrossRef
14.
go back to reference Prado CMM. Body composition in chemotherapy: The promising role of CT scans. Curr Opin Clin Nutr Metab Care. 2013;16:525–33.CrossRefPubMed Prado CMM. Body composition in chemotherapy: The promising role of CT scans. Curr Opin Clin Nutr Metab Care. 2013;16:525–33.CrossRefPubMed
15.
go back to reference Carey EJ, Lai JC, Wang CW, et al. A multicenter study to define sarcopenia in patients with end-stage liver disease. Liver Transplant. 2017;23:625–33. Carey EJ, Lai JC, Wang CW,  et al. A multicenter study to define sarcopenia in patients with end-stage liver disease. Liver Transplant. 2017;23:625–33.
16.
go back to reference Frederiksen H, Hjelmborg J, Mortensen J, McGue M, Vaupel JW, Christensen K. Age trajectories of grip strength: Cross-sectional and longitudinal data among 8,342 Danes aged 46 to 102. Ann Epidemiol. 2006;16:554–62.CrossRefPubMed Frederiksen H, Hjelmborg J, Mortensen J, McGue M, Vaupel JW, Christensen K. Age trajectories of grip strength: Cross-sectional and longitudinal data among 8,342 Danes aged 46 to 102. Ann Epidemiol. 2006;16:554–62.CrossRefPubMed
17.
go back to reference Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing. 2019 01;48:16–31. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing. 2019 01;48:16–31.
18.
go back to reference Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: Association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49:M85-94.CrossRefPubMed Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: Association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49:M85-94.CrossRefPubMed
19.
go back to reference Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.
20.
go back to reference Younossi Z, Guyatt G, Kiwi M, Boparai N, King D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut. 1999;45:295–300.CrossRefPubMedPubMedCentral Younossi Z, Guyatt G, Kiwi M, Boparai N, King D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut. 1999;45:295–300.CrossRefPubMedPubMedCentral
21.
go back to reference Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121–3. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121–3.
22.
go back to reference de Souza NP, Villar LM, Garbin AJÍ, Rovida TAS, Garbin CAS. Assessment of health-related quality of life and related factors in patients with chronic liver disease. Braz J Infect Dis. 2015;19:590–5.CrossRefPubMedPubMedCentral de Souza NP, Villar LM, Garbin AJÍ, Rovida TAS, Garbin CAS. Assessment of health-related quality of life and related factors in patients with chronic liver disease. Braz J Infect Dis. 2015;19:590–5.CrossRefPubMedPubMedCentral
23.
go back to reference Parkash O, Iqbal R, Jafri F, Azam I, Jafri W. Frequency of poor quality of life and predictors of health related quality of life in cirrhosis at a tertiary care hospital Pakistan. BMC Res Notes. 2012;20:446.CrossRef Parkash O, Iqbal R, Jafri F, Azam I, Jafri W. Frequency of poor quality of life and predictors of health related quality of life in cirrhosis at a tertiary care hospital Pakistan. BMC Res Notes. 2012;20:446.CrossRef
24.
go back to reference Benjamin J, Mani K, Saraya A, Joshi YK. Translation and validation of the Hindi version of chronic liver disease questionnaire (CLDQ) for the assessment of health related quality of life in patient with chronic liver disease in India. Trop Gastroenterol. 2016;37:112–22. Benjamin J, Mani K, Saraya A, Joshi YK. Translation and validation of the Hindi version of chronic liver disease questionnaire (CLDQ) for the assessment of health related quality of life in patient with chronic liver disease in India. Trop Gastroenterol. 2016;37:112–22.
25.
26.
go back to reference Gupta R, Avasthi A, Chawla YK, Grover S. Psychiatric morbidity, fatigue, stigma and quality of life of patients with hepatitis B infection. J Clin Exp Hepatol. 2020;10:429–41.CrossRefPubMedPubMedCentral Gupta R, Avasthi A, Chawla YK, Grover S. Psychiatric morbidity, fatigue, stigma and quality of life of patients with hepatitis B infection. J Clin Exp Hepatol. 2020;10:429–41.CrossRefPubMedPubMedCentral
27.
go back to reference Rossi D, Galant LH, Marroni CA. Psychometric property of fatigue severity scale and correlation with depression and quality of life in cirrhotics. Arq Gastroenterol. 2017;54:344–8.CrossRefPubMed Rossi D, Galant LH, Marroni CA. Psychometric property of fatigue severity scale and correlation with depression and quality of life in cirrhotics. Arq Gastroenterol. 2017;54:344–8.CrossRefPubMed
28.
go back to reference Nardelli S, Gioia S, Faccioli J, Riggio O, Ridola L. Sarcopenia and cognitive impairment in liver cirrhosis: A viewpoint on the clinical impact of minimal hepatic encephalopathy. World J Gastroenterol. 2019;25:5257–65.CrossRefPubMedPubMedCentral Nardelli S, Gioia S, Faccioli J, Riggio O, Ridola L. Sarcopenia and cognitive impairment in liver cirrhosis: A viewpoint on the clinical impact of minimal hepatic encephalopathy. World J Gastroenterol. 2019;25:5257–65.CrossRefPubMedPubMedCentral
Metadata
Title
Simple bedside tests of muscle strength and function correlate with computed tomography-skeletal muscle index for assessment of sarcopenia in cirrhosis
Authors
Surender Singh
Sunil Taneja
Akash Roy
Sahaj Rathi
Arka De
Nipun Verma
Madhumita Premkumar
Ajay Duseja
R. K. Dhiman
Virendra Singh
Publication date
24-05-2023
Publisher
Springer India
Published in
Indian Journal of Gastroenterology / Issue 3/2023
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-023-01338-8

Other articles of this Issue 3/2023

Indian Journal of Gastroenterology 3/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine